image
Healthcare - Medical - Care Facilities - NYSE - US
$ 12.13
-6.4 %
$ 1.04 B
Market Cap
-10.08
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on Apr, 22, 2025.

The intrinsic value of one MD stock under the worst case scenario is HIDDEN Compared to the current market price of 12.1 USD, Pediatrix Medical Group, Inc. is HIDDEN

This DCF valuation model was last updated on Apr, 22, 2025.

The intrinsic value of one MD stock under the base case scenario is HIDDEN Compared to the current market price of 12.1 USD, Pediatrix Medical Group, Inc. is HIDDEN

This DCF valuation model was last updated on Apr, 22, 2025.

The intrinsic value of one MD stock under the best case scenario is HIDDEN Compared to the current market price of 12.1 USD, Pediatrix Medical Group, Inc. is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart MD

image
$18.0$18.0$17.0$17.0$16.0$16.0$15.0$15.0$14.0$14.0$13.0$13.0$12.0$12.0Nov '24Nov '2415 Nov15 NovDec '24Dec '2415 Dec15 DecJan '25Jan '2515 Jan15 JanFeb '25Feb '2515 Feb15 FebMar '25Mar '2515 Mar15 MarApr '25Apr '2515 Apr15 Apr
FINANCIALS
2.01 B REVENUE
0.92%
-68.7 M OPERATING INCOME
-938.57%
-99.1 M NET INCOME
-64.00%
207 M OPERATING CASH FLOW
50.43%
-35.4 M INVESTING CASH FLOW
26.51%
-14.5 M FINANCING CASH FLOW
43.67%
502 M REVENUE
-1.72%
39.3 M OPERATING INCOME
16.15%
30.5 M NET INCOME
56.78%
133 M OPERATING CASH FLOW
32.06%
-1.94 M INVESTING CASH FLOW
55.33%
-4.96 M FINANCING CASH FLOW
-61.61%
Balance Sheet Pediatrix Medical Group, Inc.
image
Current Assets 640 M
Cash & Short-Term Investments 349 M
Receivables 273 M
Other Current Assets 18.5 M
Non-Current Assets 1.51 B
Long-Term Investments 0
PP&E 78.4 M
Other Non-Current Assets 1.43 B
16.19 %12.66 %3.64 %66.64 %Total Assets$2.2b
Current Liabilities 434 M
Accounts Payable 46.4 M
Short-Term Debt 33.2 M
Other Current Liabilities 354 M
Non-Current Liabilities 954 M
Long-Term Debt 629 M
Other Non-Current Liabilities 325 M
3.35 %25.54 %45.33 %23.39 %Total Liabilities$1.4b
EFFICIENCY
Earnings Waterfall Pediatrix Medical Group, Inc.
image
Revenue 2.01 B
Cost Of Revenue 0
Gross Profit 2.01 B
Operating Expenses 2.08 B
Operating Income -68.7 M
Other Expenses 30.4 M
Net Income -99.1 M
3b3b2b2b2b2b1b1b500m500m00(500m)(500m)2b02b(2b)(69m)(30m)(99m)RevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income
RATIOS
100.00% GROSS MARGIN
100.00%
-3.41% OPERATING MARGIN
-3.41%
-5.15% NET MARGIN
-5.15%
-13.55% ROE
-13.55%
-4.81% ROA
-4.81%
-3.83% ROIC
-3.83%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Pediatrix Medical Group, Inc.
image
500m500m450m450m400m400m350m350m300m300m250m250m200m200m150m150m100m100m50m50m0020162016201720172018201820192019202020202021202120222022202320232024202420252025
Net Income -99.1 M
Depreciation & Amortization 33.2 M
Capital Expenditures -22 M
Stock-Based Compensation 11.9 M
Change in Working Capital 88.2 M
Others 201 M
Free Cash Flow 185 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets Pediatrix Medical Group, Inc.
image
Wall Street analysts predict an average 1-year price target for MD of $11.2 , with forecasts ranging from a low of $8 to a high of $14 .
MD Lowest Price Target Wall Street Target
8 USD -34.05%
MD Average Price Target Wall Street Target
11.2 USD -7.25%
MD Highest Price Target Wall Street Target
14 USD 15.42%
Price
Max Price Target
Min Price Target
Average Price Target
181816161414121210108866Jun '24Jun '24Jul '24Jul '24Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26
4. DIVIDEND ANALYSIS
5. COMPETITION
slide 2 of 5
6. Ownership
Insider Ownership Pediatrix Medical Group, Inc.
image
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
553 K USD 2
6-9 MONTHS
702 K USD 3
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
Pediatrix Medical Group 2025 First Quarter Conference Call/Webcast Scheduled for Tuesday, May 6, 2025 FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--Pediatrix Medical Group 2025 First Quarter Conference Call/Webcast Scheduled for Tuesday, May 6, 2025. businesswire.com - 1 week ago
MD or HQY: Which Is the Better Value Stock Right Now? Investors interested in Medical Services stocks are likely familiar with Pediatrix Medical Group (MD) and HealthEquity (HQY). But which of these two stocks is more attractive to value investors? zacks.com - 2 weeks ago
Why Pediatrix Medical Group (MD) is a Top Value Stock for the Long-Term Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service. zacks.com - 3 weeks ago
Here Is Why Bargain Hunters Would Love Fast-paced Mover Pediatrix Medical Group (MD) If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Pediatrix Medical Group (MD) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen. zacks.com - 4 weeks ago
MD vs. HQY: Which Stock Is the Better Value Option? Investors interested in Medical Services stocks are likely familiar with Pediatrix Medical Group (MD) and HealthEquity (HQY). But which of these two stocks offers value investors a better bang for their buck right now? zacks.com - 4 weeks ago
Here's Why Pediatrix Medical Group (MD) is a Strong Momentum Stock Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service. zacks.com - 4 weeks ago
5 Relative Price Strength Stocks to Navigate Today's Market IHS, ANIP, MD, FMS and TREE are five stocks with explosive relative price strength. zacks.com - 1 month ago
3 Medical Services Industry Stocks to Buy as AI Fuels Growth The Zacks Medical - Services industry is undergoing a transformation on massive artificial intelligence adoption. COR, DOCS and MD are set to gain the most. zacks.com - 1 month ago
Wall Street Analysts Think Pediatrix Medical Group (MD) Could Surge 27.97%: Read This Before Placing a Bet The consensus price target hints at a 28% upside potential for Pediatrix Medical Group (MD). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term. zacks.com - 1 month ago
Fast-paced Momentum Stock Pediatrix Medical Group (MD) Is Still Trading at a Bargain Pediatrix Medical Group (MD) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen. zacks.com - 1 month ago
MD vs. HQY: Which Stock Should Value Investors Buy Now? Investors with an interest in Medical Services stocks have likely encountered both Pediatrix Medical Group (MD) and HealthEquity (HQY). But which of these two stocks is more attractive to value investors? zacks.com - 1 month ago
Pediatrix Medical Stock Rallies 37.7% in 6 Months: More Room to Run? MD is expected to benefit from rising patient volumes, a favorable payer mix and streamlining initiatives. zacks.com - 1 month ago
8. Profile Summary

Pediatrix Medical Group, Inc. MD

image
COUNTRY US
INDUSTRY Medical - Care Facilities
MARKET CAP $ 1.04 B
Dividend Yield 0.00%
Description Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States and Puerto Rico. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians. The company also provides maternal-fetal care services, including inpatient and office-based clinical care to expectant mothers and unborn babies through affiliated maternal-fetal medicine subspecialists, as well as obstetricians and other clinicians, including maternal-fetal nurse practitioners, certified nurse mid-wives, ultrasonographers, and genetic counselors. In addition, it offers pediatric cardiology care services comprising inpatient and office-based pediatric cardiology care of the fetus, infant, child, and adolescent patient with congenital heart defects and acquired heart disease, as well as adults with congenital heart defects through affiliated pediatric cardiologist subspecialists and other related clinical professionals; and specialized cardiac care to the fetus, neonatal and pediatric patients. Further, the company provides other pediatric subspecialty care services through pediatric subspecialists, such as pediatric intensivists, pediatric hospitalists, pediatric surgeons, and pediatric ophthalmologists, as well as pediatric ear, nose, and throat physicians; and support services in the areas of hospitals, primarily in the pediatric emergency rooms, labor and delivery areas, and nursery and pediatric departments. As of February 17, 2022, it operated a network of approximately 2,700 physicians. The company was formerly known as MEDNAX, Inc. and changed its name to Pediatrix Medical Group, Inc. in July 2022. Pediatrix Medical Group, Inc. was founded in 1979 and is based in Sunrise, Florida.
Contact 1301 Concord Terrace, Sunrise, FL, 33323 https://www.mednax.com
IPO Date Sept. 20, 1995
Employees 4120
Officers Ms. Debra McRoberts Senior Vice President of People Services Ms. Nanette Sanders Senior Vice President of Operations Ms. Cheryl M. VanPatten Senior Vice President & Chief Information Officer Ms. Mary Ann E. Moore J.D. Chief Administrative Officer, Executive Vice President, General Counsel & Secretary Mr. Daniel Patrick Corcoran Senior Vice President of Administration & Managed Care Ms. Kasandra H. Rossi Executive Vice President, Treasurer & Chief Financial Officer Mr. Mike Ashford President of South Central Division Mr. John C. Pepia Senior Vice President & Chief Accounting Officer Mr. Mark S. Ordan Chief Executive Officer & Executive Chairman Mr. Kevin Pitzer President of West Division